Sugi Predict

Sugi Predict / Compounds / SCHEMBL29436331

SCHEMBL29436331

SCHEMBL29436331

CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)O

nearest known ligand 0.70

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ IL23R Q5VWK5 12/20 0.70
▸ NPY1R P25929 1/20 0.65
▸ NPY2R P49146 1/20 0.65
▸ NPY4R P50391 1/20 0.65
▸ NPY5R Q15761 1/20 0.65
▸ CXCR4 P61073 5/20 0.63
▸ C5AR1 P21730 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29672871 0.97 IL23R (0.70) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30436762 0.92 IL23R (0.72) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL38661970 0.90 IL23R (0.67) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL31433256 0.90 IL23R (0.62) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL31182831 0.90 CXCR4 (0.68) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL29697189 0.90 KISS1R (0.65) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30607479 0.90 NPY1R (0.68) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30906500 0.89 NPY1R (0.66) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL31694495 0.89 IL23R (0.64) IL23RNPY1RNPY2RNPY4RNPY5R
SCHEMBL31182825 0.89 IL23R (0.65) IL23RNPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473332-B2 Modified peptides and associated methods of use ADVANCED TECH FOR NOVEL THERAPEUTICS LLC (US) 2025-11-18 — — US disclosed
US-20240083948-A1 MODIFIED PEPTIDES AND ASSOCIATED METHODS OF USE ADVANCED TECHNOLOGIES FOR NOVEL THERAPEUTICS, LLC (US) 2024-03-14 — — US disclosed
US-11820837-B2 Modified peptides and associated methods of use ADVANCED TECHNOLOGIES FOR NOVEL THERAPEUTICS, LLC (US) 2023-11-21 — — US disclosed
CN-114174316-A Modified peptides and related methods of use 新颖疗法的先进技术有限责任公司 2022-03-11 — — CN disclosed
Send feedback